Researchers apply Dihexa to investigate its high-affinity interaction with hepatocyte growth factor (HGF), resulting in potentiated c-Met receptor activation at subthreshold ligand concentrations. Pre-clinical observations in neuronal models indicate enhanced synaptogenesis, increased dendritic arborization, and recovery of synaptic markers in impairment paradigms.
This stabilized oligopeptide facilitates examination of HGF/c-Met-mediated cascades that support neuronal connectivity, synaptic plasticity, and adaptive responses under stress or pathological conditions.
Scientific Overview of Dihexa Applications
Pre-clinical models demonstrate Dihexa’s engagement with HGF/c-Met-related mechanisms:
- High-affinity binding to HGF and potentiation of c-Met phosphorylation, promoting cellular scattering and downstream signaling in the presence of low HGF levels in cellular assays. https://pubmed.ncbi.nlm.nih.gov/25187433/
- Induction of synaptogenesis and dendritic spine formation through HGF/c-Met pathway augmentation in neuronal culture systems.
- Restoration of cognitive performance and synaptic protein expression via PI3K/AKT signaling modulation in APP/PS1 transgenic mouse models. https://pubmed.ncbi.nlm.nih.gov/34827486/
- Support for neuroregenerative processes in scopolamine-induced cognitive impairment paradigms, with evidence of enhanced synaptic plasticity markers.
- Protection of sensory hair cells from aminoglycoside-induced damage through HGF/c-Met activation in lateral line models. https://pubmed.ncbi.nlm.nih.gov/25674052/
- Examination of oral bioavailability, blood-brain barrier penetration, and limb function recovery support in nerve damage-repair rodent studies. https://pubmed.ncbi.nlm.nih.gov/34703584/
For further details on HGF/c-Met receptor potentiation, synaptogenic peptides, and neuroplasticity mechanisms in pre-clinical research, refer to the Peptide Sciences or About Peptides sections.
Why Investigators Select National Science Labs Dihexa
National Science Labs manufactures Dihexa under rigorous GMP-compliant protocols to ensure batch-to-batch consistency and reliability for pre-clinical experiments. Independent third-party testing verifies each lot for:
- Purity ≥99.9% by HPLC
- Structural identity confirmation via mass spectrometry
- Complete Certificate of Analysis (CoA) documentation provided per batch
For Research Use Only. This product is supplied exclusively for in vitro and in vivo pre-clinical research by qualified investigators. Statements about this peptide have not been evaluated by the FDA.
Initiate Your Dihexa Research Protocol
Source high-purity Dihexa from current limited batches to ensure optimal stability and performance in synaptogenesis and neurodegenerative studies.
